Invention Grant
- Patent Title: Benzodioxane modulators of leukotriene A4 hydrolase (LTA4H) for prevention and treatment of aging-associated diseases
-
Application No.: US17977687Application Date: 2022-10-31
-
Publication No.: US11957671B2Publication Date: 2024-04-16
- Inventor: Meghan Kerrisk Campbell , Eva Czirr , Reema Harish
- Applicant: Alkahest, Inc.
- Applicant Address: US CA San Carlos
- Assignee: Alkahest, Inc.
- Current Assignee: Alkahest, Inc.
- Current Assignee Address: US CA San Carlos
- Agency: Bozicevic, Field & Francis LLP
- Agent Todd W. Esker; Bret E. Field
- Main IPC: A61K31/453
- IPC: A61K31/453 ; A61P25/28
Abstract:
This invention pertains to the prevention and treatment of aging-associated disease. The invention relates to the use of benzodioxane inhibitors of leukotriene production through modulation of leukotriene A4 hydrolase (“LTA4H”) to treat and/or prevent conditions associated with aging such as cognitive disorders, motor disorders, and neuroinflammation.
Public/Granted literature
Information query
IPC分类:
